Published in Cancer Weekly, July 27th, 2004
One FDA clearance covers the Temporal Comparison software module, providing the ability to automatically track lung nodule progression or regression over time. Growth rate is one important indicator of clinical significance of the finding and automating this process has potential for significant time savings. The second clearance is for the Filling Defect Indicator software module, designed to help physicians visualize and evaluate filling...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.